FindTrial
Sign In

A single arm study for combination of traditional Chinese and Western Medicine in the treatment of novel coronavirus pneumonia (COVID-19)

A single arm study for combination of traditional Chinese and Western Medicine in the treatment of novel coronavirus pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029437
Enrollment
Unknown
Registered
2020-02-01
Start date
2020-02-03
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Case series:according to guidelines

Sponsors

Hubei Provincial Integrated Hospital of traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inpatient patients diagnosed as neumonia caused by new coronavirus infection.

Exclusion criteria

Exclusion criteria: Doctor's judgment is not suitable for the study.

Design outcomes

Primary

MeasureTime frame
all available outcome;—

Countries

China

Contacts

Public ContactXia Wenguang, An Changqing, Zhang Boli

Hubei integrated hospital of traditional Chinese and Western Medicine

DOCXWG@16.COM+86 13902020873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026